SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-141809
Filing Date
2024-05-17
Accepted
2024-05-17 16:38:43
Documents
18
Period of Report
2024-05-17
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d757512d8k.htm   iXBRL 8-K 30712
2 EX-99.1 d757512dex991.htm EX-99.1 11371
7 GRAPHIC g757512snap2.jpg GRAPHIC 6974
8 GRAPHIC g757512snap3.jpg GRAPHIC 5118
9 GRAPHIC g757512snap5.jpg GRAPHIC 7822
  Complete submission text file 0001193125-24-141809.txt   235628

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20240517.xsd EX-101.SCH 3101
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20240517_def.xml EX-101.DEF 13867
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20240517_lab.xml EX-101.LAB 22898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20240517_pre.xml EX-101.PRE 14705
22 EXTRACTED XBRL INSTANCE DOCUMENT d757512d8k_htm.xml XML 6001
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 24960501
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)